{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:44:49Z","timestamp":1785293089993,"version":"3.55.0"},"reference-count":31,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Cellulitis is a common acute skin and soft tissue infection with high rates of recurrence. Historically, guidelines for care have focused on pharmacological management; however, emerging evidence supports the benefits of non\u2010pharmacological approaches for risk mitigation and recurrence prevention. This review examined best practice guidelines for the management of cellulitis\u2014for the inclusion of recommendations beyond antibiotics to prevent recurrence. A systematic search of seven databases was conducted, including the Guidelines International Network (GIN), the Agency for Healthcare Research and Quality and the Australian National Health and Medical Research Council clinical practice guidelines. Guidelines were included if they addressed lower limb cellulitis, were developed after 2000, published in English, appeared in a peer\u2010reviewed journal and\/or were endorsed by a health agency or government body, and contained recommendations for non\u2010pharmacological management. The Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool was used to assess guideline quality. Ten guidelines met the inclusion criteria. Recommendations for non\u2010pharmacological management and recurrence prevention primarily addressed risk factors such as venous disease, oedema, tinea, skin barrier integrity and obesity. However, these recommendations were often brief and lacked actionable strategies for managing local risk factors effectively. Most guidelines scored poorly in the AGREE II assessment, particularly in rigour of development, despite performing well in scope, purpose and clarity. Furthermore, non\u2010pharmacological strategies and recurrence prevention remain underdeveloped. Strengthening the evidence base and incorporating targeted prevention strategies will be essential to improving future guidelines, ultimately enhancing patient outcomes and reducing the burden on healthcare systems.<\/jats:p><jats:p><jats:bold>Trial Registration:<\/jats:bold> Registered with Open Science Framework OSF: osf\u2010registrations\u20107wkvf\u2010v1<\/jats:p>","DOI":"10.1111\/ajd.14546","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T08:20:26Z","timestamp":1750234826000},"page":"321-328","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Systematic Review of Cellulitis Guidelines: The Role of Non\u2010Pharmacological Management in Preventing Recurrence"],"prefix":"10.1111","volume":"66","author":[{"given":"Janette","family":"Jacka","sequence":"first","affiliation":[{"name":"Sydney School of Health Sciences, Faculty of Medicine and Health The University of Sydney  Sydney Australia"},{"name":"Department of Occupational Therapy Royal Prince Alfred Hospital  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8115-5631","authenticated-orcid":false,"given":"Robyn","family":"Sierla","sequence":"additional","affiliation":[{"name":"Sydney School of Health Sciences, Faculty of Medicine and Health The University of Sydney  Sydney Australia"},{"name":"Department of Occupational Therapy Royal Prince Alfred Hospital  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Kilbreath","sequence":"additional","affiliation":[{"name":"Sydney School of Health Sciences, Faculty of Medicine and Health The University of Sydney  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Dylke","sequence":"additional","affiliation":[{"name":"Sydney School of Health Sciences, Faculty of Medicine and Health The University of Sydney  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.8825"},{"key":"e_1_2_9_3_1","volume-title":"Australian Atlas of Healthcare Variation 2021","author":"2021, The Australian Commission on Safety and Quality in Healthcare","year":"2021"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.01.023"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-029225"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.10.001"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2022.0029"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2019.11.014"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13671-020-00287-1"},{"key":"e_1_2_9_10_1","volume-title":"Guidelines on the Management of Cellulitis in Adults","author":"Fulton R.","year":"2005"},{"key":"e_1_2_9_11_1","unstructured":"British Lymphology Society (BLS) \u201cGuidelines on the Management of Cellulitis in Lymphoedema \u201d2022 https:\/\/www.thebls.com\/documents\u2010library\/guidelines\u2010on\u2010the\u2010management\u2010of\u2010cellulitis\u2010in\u2010lymphoedema."},{"key":"e_1_2_9_12_1","unstructured":"Australasian Lymphology Association (ALA) \u201cConsensus Guideline: Management of Cellulitis in Lymphoedema 2015 \u201dhttps:\/\/www.lymphoedema.org.au\/about\u2010lymphoedema\/consensus\u2010guideline\/."},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009758.pub2"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.4.638-656.2005"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.0884"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19803"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15186"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090449"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214846"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27461"},{"issue":"6","key":"e_1_2_9_21_1","first-page":"1","article-title":"Quality Assessment of Osteoporosis Clinical Practice Guidelines for Physical Activity and Safe Movement: An AGREE II Appraisal","volume":"11","author":"Armstrong J. J.","year":"2016","journal-title":"Archives of Osteoporosis"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/1120009X.2017.1311398"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13790"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13017-018-0219-9"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2017.49.4.301"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu444"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2014.04.018"},{"issue":"6","key":"e_1_2_9_28_1","first-page":"465","article-title":"Erysipelas and Necrotizing Fasciitis: Management (Short Text)","volume":"151","author":"Anon","year":"2000","journal-title":"Consensus Conference. French Society of Dermatology. Annales de Medecine Interne (Paris)"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1086\/497143"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gerinurse.2004.09.009"},{"issue":"3","key":"e_1_2_9_31_1","first-page":"16","article-title":"Management Guidelines for Lower Limb Cellulitis","volume":"1","author":"Beldon P.","year":"2005","journal-title":"Wounds UK"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2020.09.018"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajd.14546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:13:00Z","timestamp":1757409180000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajd.14546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1111\/ajd.14546"],"URL":"https:\/\/doi.org\/10.1111\/ajd.14546","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"2025-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}